Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer: The VIABLE Phase 3 Randomized Clinical Trial
自体树突状细胞免疫疗法、多西他赛和泼尼松与安慰剂治疗转移性去势抵抗性前列腺癌患者的疗效和安全性:VIABLE III期随机临床试验
期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2021.7298
Vogelzang, Nicholas J; Beer, Tomasz M; Gerritsen, Winald; Oudard, Stéphane; Wiechno, Pawel; Kukielka-Budny, Bozena; Samal, Vladimir; Hajek, Jaroslav; Feyerabend, Susan; Khoo, Vincent; Stenzl, Arnulf; Csöszi, Tibor; Filipovic, Zoran; Goncalves, Frederico; Prokhorov, Alexander; Cheung, Eric; Hussain, Arif; Sousa, Nuno; Bahl, Amit; Hussain, Syed; Fricke, Harald; Kadlecova, Pavla; Scheiner, Tomas; Korolkiewicz, Roman P; Bartunkova, Jirina; Spisek, Radek
肿瘤
肿瘤免疫
树突状细胞
细胞生物学
前列腺癌
树突状细胞
免疫/内分泌